Mymetics Corp (MYMX)
Mymetics Corp is a common stock listing of Mymetics Corporation, a healthcare biotechnology company based in Epalinges, Switzerland. The company focuses on research and development of vaccines for infectious and life-disabling diseases. Its pipeline includes candidates targeting HIV-1/AIDS, COVID-19, intranasal influenza, respiratory syncytial virus, and malaria. Mymetics has also entered into collaboration agreements with Texas Biomedical Research Institute and the National Institutes of Health. Founded in 1990, the company was previously known as ICHOR Corporation and adopted the Mymetics name in July 2001.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Market Cap |
|---|---|---|---|---|---|---|---|
|
OTC-MYMX
|
Not available
|
Not available
|
Not available
|
Fair
|
0.0%
|
November 20, 2026
|
0.045 K
|